Hero image with Pittsburgh background pittplusme.org/study/1949

STUDY BASICS

Are you the parent of a child ages 7-17 who has eczema? Your child may be able to participate in a study to find out if a new study drug (a cream) works and is safe to use on eczema. This study includes 5 in-person visits and involves putting the study cream (or placebo) on every night for 28 nights and undergoing two blood draws. Compensation is provided.


IRB:
  SSU00137808A - Arcutis Biotherapeutics, Inc. - ARQ-151-312, A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.15% Administered QD in Subjects with Atopic Dermatitis (Pro00047993)


Age Range
AGE:   7-17

Duration DURATION:  Up to 8 weeks
VISITS:  5

Location LOCATION: 
Falk Medical Building - Oakland
Compensation COMPENSATION: 

YES

Phone Number PHONE NUMBER:
1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In
Search Icon pittplusme.org/study/1949
OR
Phone Number PHONE NUMBER:
1-866-438-8230

MEET THE RESEARCHER


Laura Ferris

Laura Korb Ferris, MD, PhD, is Associate Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.




PittPlusMe.org 1-866-438-8230 PittPlusMe@pitt.edu
@PittPlusMe share tweet